Pharmacotherapy of postpartum depression

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 16, 2009, Pages 2593-2607

  Di Scalea, Teresa Lanza ^a,b   Wisner, Katherine L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Pharmacotherapy; Postpartum depression; Prevention; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CONJUGATED ESTROGEN; DOXEPIN; DYDROGESTERONE; ESTRADIOL; ESTROGEN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LORAZEPAM; NORETHISTERONE ENANTATE; NORTRIPTYLINE; PAROXETINE; PLACEBO; PROGESTERONE; SERTRALINE; VENLAFAXINE; ZOLPIDEM;

ANXIETY DISORDER; BREAST FEEDING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ENDOMETRIUM; HORMONAL THERAPY; HUMAN; MAJOR DEPRESSION; PATIENT COUNSELING; PROPHYLAXIS; PSYCHOTHERAPY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; BREAST FEEDING; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 72949094611     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903277202     Document Type: Review

References (65)

1. APA, Diagnostic and statistical manual of mental disorders, 4th edition. Washington: American Psychiatry Association; 1994
2. WHO, classification of mental and behavioral disorders-clinical descriptions and diagnostic guidelines ICD-10. 10th edition. Geneva: World Health Organization; 1992
3. Gaynes B, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. 2005 [Last accessed 21 April 2009]. Available from: http://www.ahrq.gov/downloads/ pub/evidence/pdf/ peridepr/peridep.pdf
4. O'Hara M, Swain A. Rates and risk of postpartum depression: a meta analysis. Int Rev Psychiatry 1996;8:37-54
5. Munk-Olsen T, et al. New parents and mental disorders: a population-based register study. JAMA 2006;296(21):2582-2589
6. Nonacs R, Cohen LS. Postpartum psychiatric syndromes. Kaplan & Sadock's comprehensive textbook of psychiatry. In: Sadock BJ, Sadock VA, editors. Philadelphia, PA; 2000. p. 1276-1283
7. Angold A, Worthman C. Puberty onsent of gender differences in rates of depression: a developmental, epidemiological, and neuroendocrine perspective. J Affect Disord 1993;29:145-158
8. Bebbington P, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 1998;28:9-19
9. Wisner KL, Peindl K, Hanusa BH. Symptomatology of affective and psychotic illnesses related to childbearing. J Affect Disord 1994;30(2):77-87
10. Cooper PJ, Campbell EA, Day A, et al. Non-psychotic psychiatric disorder after childbirth. A prospective study of prevalence, incidence, course and nature. Br J Psychiatry 1988;152:799-806
11. Wisner KL, Peindl KS, Gigliotti T, et al. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999;60(3):176-180
12. Parry BL. Postpartum psychiatric syndromes. Comprehensive textbook of psychiatry volume1, 4th edition. In: Kaplan SBH, editors. Philadelphia: Williams & Wilkins; 1995
13. Parry BL. Mood disorders linked to the reproductive cycle in women, in psychopharmacology: the Fourth Generation of Progress. In: Bloom FE, Kupfer DJ, editors. Raven Press, Ltd.: New York; 1995. p. 1029-1042
14. Russell JA, Douglas AJ, Ingram CD. Brain preparations for maternity-adaptive changes in behavioral and neuroendocrine systems during pregnancy and lactation. An overview. Prog Brain Res 2001;133:1-38
15. O'Hara MW, Schlechte JA, Lewis DA, et al. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol 1991;100(1):63-73
16. Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157(6):924-930
17. Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 2001;62(2):82-86
18. Hay DF, Pawlby S, Waters CS, et al. Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes. J Child Psychol Psychiatry 2008;49(10):1079-1088
19. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992;33(3):543-561
20. Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hosp Commun Psychiatry 1994;45(12):1191-1196
21. Sichel DA, Cohen LS, Robertson LM, et al. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38(12):814-818
22. Dalton K. Progesterone prophylaxis used successfully in postnatal depression. Practitioner 1985;229:507-508
23. Dalton K. Successful prophylactic progesterone for idiopathic postnatal depression. Int J Prenat Perinat Stud 1989;1:323-327
24. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150:662-673
25. Wisner KL, Perel JM, Peindl KS, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry 2004;161(7):1290-1292
26. APA, American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders. American Psychiatric Publishing, Inc.; 2006
27. Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 1999;96(23):13512-13517
28. Britton KT, Koob GF. Neuropharmacology. Premenstrual steroids? Nature 1998;392(6679):869-870
29. Lawrie TA, Hofmeyr GJ, De Jager M, et al. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 1998;105(10):1082-1090
30. Roy A, Cole K, Goldman Z, et al. Fluoxetine treatment of postpartum depression. Am J Psychiatry 1993;150(8):1273
31. Stowe Z, Casarella J, Landry J, Nemeroff CB. Sertraline in the treatment of women with postpartum major depression. Depression 1995;3:49-55
32. Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 2001;62(8):592-596
33. Suri R, Burt VK, Altshuler LL, et al. Fluvoxamine for postpartum depression. Am J Psychiatry 2001;158(10):1739-1740
34. Nonacs RM, Soares CN, Viguera AC, et al. Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 2005;8(3):445-449
35. Ahokas AJ, Turtiainen S, Aito M. Sublingual oestrogen treatment of postnatal depression. Lancet 1998;351(9096):109
36. Ahokas A, Kaukoranta J, Wahlbeck K, et al. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 2001;62(5):332-336
37. Wisner KL, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006;26(4):353-360
38. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997;314(7085):932-936
39. Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004;65(9):1236-1241
40. Yonkers KA, Lin H, Howell HB, et al. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 2008;69(4):659-665
41. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347(9006):930-933
42. Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287(14):1840- 1847
43. Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 2005;66(2):148-158
44. Goldman AS, Hopkinson JM, Rassin DK. Benefits and risks of breastfeeding. Adv Pediatr 2007;54:275-304
45. Pearlstein TB, Zlotnick C, Battle CL, et al. Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health 2006;9(6):303-308
46. Battle CL, Zlotnick C, Pearlstein T, et al. Depression and breastfeeding: which postpartum patients take antidepressant medications? Depress Anxiety 2008;25(10):888-891
47. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004;161(6):1066-1078
48. Lanza di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 2009. In press
49. Epperson CN, Jatlow PI, Czarkowski K, et al. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 2003;112(5):e425
50. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158(10):1631-1637
51. Wisner KL, Chambers C, Sit DK. Postpartum depression: a major public health problem. JAMA 2006;296(21):2616-2618
52. Elliott S. Report on the satra bruk workshop on classification of postnatal mental disorders on november 7-10, 1999, convened by Birgitta Wickberg, Philip Hwang and John Cox with the support of Allmanna Barhuset represented by Marina Gronros. Arch Womens Mental Health 2000;3:27-33
53. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry 1987;150:782-786
54. O'Hara M. Postpartum depression: identification and measurement in a cross-cultural context. In: Cox J, Holden J, editors. Perinatal Psychiatry, Gaskell, London; 1994. p. 161-162
55. Beck CT, Gable RK. Comparative analysis of the performance of the postpartum depression screening scale with two other depression instruments. Nurs Res 2001;50(4):242-250
56. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006;166(21):2314-2321
57. Sit D, et al. An emerging best practice model for perinatal depression care. Psychiatr Serv. In press
58. NICE. Antenatal and postnatal mental health: clinical management and service guidance, clinical guideline no. 45. 2007 [Last accessed 10 July 2009]. Available from: http://www.nice.org.uk/nicemedia/ pdf/ CG045NICEGuidelineCorrected.pdf
59. Chaudron L, Giannandrea S. The Academy of Breastfeeding Medicine Protocol Committee clinical protocol #18: use of antidepressants in nursing mothers. Breastfeed Med 2008;3(1):44-52
60. ACOG, Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111(4):1001-1020
61. Sit DKY, Wisner KL. Decision making for postpartum depression treatment. Psychiatr Ann 2005;35(7):577-584
62. Perheentupa A, Ruokonen A, Tapanainen JS. Transdermal estradiol treatment suppresses serum gonadotropins during lactation without transfer into breast milk. Fertil Steril 2004;82(4):903-907
63. Booker DE, Pahyl IR. Control of postpartum breast engorgement with oral contraceptives. Am J Obstet Gynecol 1967;98:1099-1101
64. Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163(11):1905-1917
65. Freeman MP. Complementary and alternative medicine for perinatal depression. J Affect Disord 2009;112(1-3):1-10